各種尿路感染症に対するSulfamethoxazole-Trimethoprim合剤の臨床効果

熊沢 浄一; 百瀬 俊郎; 平田 耕造; 日高 正昭; 江本 侃一; 東間 紘; 原 三信; 原 孝彦; 後藤 宏一郎; 南里 和成; 石津 芳和; 有吉 朝美; 楢橋 勝利; 永芳 弘之; 中山 宏; 岩坪 映二; 王丸 鴻一; 清原 宏彦; 平田 弘; 長田 幸夫

doi:10.11250/chemotherapy1953.21.491

CLINICAL EXPERIENCES OF SULFAMETHOXAZOLE-TRIMETHOPRIM COMBINATION ON URINARY TRACT INFECTION

JYOICHI KUMAZAWA, SHUNRO MOMOSE, KOZO HIRATA, MASAAKI HIDAKA, KANICHI EMOTO, HIROSHI TOMA, SANSHIN HARA, TAKAHIKO HARA, KOICHIRO GOTO, KAZUNARI NANRI, YOSHIKAZU ISHIZU, ASAMI ARIYOSHI, KATSUTOSHI NARAHASHI, HIROYUKI NAGAYOSHI, HIROSHI NAKAYAMA, EIJI IWATSUBO, KOICHI OMARU, HIROHIKO KIYOHARA, HIROSHI HIRATA, YUKIO OSADA

Author information

JYOICHI KUMAZAWA
Department of Urology, Kyushu University
SHUNRO MOMOSE
Department of Urology, Kyushu University
KOZO HIRATA
Department of Urology, Fukuoka National Hospital
MASAAKI HIDAKA
Department of Urology, Fukuoka National Hospital
KANICHI EMOTO
Department of Urology, Hamanomachi Hospital
HIROSHI TOMA
Department of Urology, Hamanomachi Hospital
SANSHIN HARA
Sanshinkai Hara Hospital
TAKAHIKO HARA
Sanshinkai Hara Hospital
KOICHIRO GOTO
Sanshinkai Hara Hospital
KAZUNARI NANRI
Sanshinkai Hara Hospital
YOSHIKAZU ISHIZU
Department of Urology, Kitakyushu Shiritsu-Moji Hospital
ASAMI ARIYOSHI
Department of Urology, Kokura National Hospital
KATSUTOSHI NARAHASHI
Department of Urology, Kokura National Hospital
HIROYUKI NAGAYOSHI
Department of Urology, Shinnihonseitetsu Yahata Hospital
HIROSHI NAKAYAMA
Department of Urology, Beppu National Hospital
EIJI IWATSUBO
Department of Urology, Beppu National Hospital
KOICHI OMARU
Department of Urology, Miyazaki Kenritsu Hospital
HIROHIKO KIYOHARA
Department of Urology, Miyazaki Kenritsu Hospital
HIROSHI HIRATA
Department of Urology, Hiroshima Red Cross Hospital
YUKIO OSADA
Department of Urology, Hiroshima Red Cross Hospital

JOURNAL FREE ACCESS

1973 Volume 21 Issue 2 Pages 491-497

DOI https://doi.org/10.11250/chemotherapy1953.21.491

Details

Abstract

In order to test the value in the treatment of urinary tract infection, 72 patients with infections of varying severity and due to a wide range of organisms were treated with SMX-TMP combination product.
SMX-TMP combiation product was administered orally 2 tablets two times daily.
Satisfactory results were obtained in 95. 8% of 48 non-specific urinary tract infection cases, whereas 58.5% of 24 complicated cases. In total, satisfactory results were 83. 8%. No side effect was obtained except 4 cases.
It is evaluated that SMX-TMP combination product is a useful antibacterial agent for the urinary tract infection.

Corresponding author

Register with J-STAGE for free!